Novavax Inc. Stock Falls Monday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) shed 5.67% to $10.65 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 1.96% to 11,393.81 and Dow Jones Industrial Average falling 0.77% to 33,717.09. Novavax Inc. closed $90.74 below its 52-week high ($101.39), which the company achieved on February 7th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 3.70% to $162.00, Pfizer Inc. (PFE) fell 0.55% to $43.55, and Merck & Co. Inc. (MRK) rose 0.67% to $106.09. Trading volume (7.7 M) eclipsed its 50-day average volume of 7.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 30, 2023.
(END) Dow Jones Newswires
January 30, 2023 17:15 ET (22:15 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.